Literature DB >> 9724308

Proinflammatory cytokines depress cardiac efficiency by a nitric oxide-dependent mechanism.

D Panas1, F H Khadour, C Szabó, R Schulz.   

Abstract

Proinflammatory cytokines (interleukin-1beta, tumor necrosis factor-alpha, and interferon-gamma; Cytomix) depress myocardial contractile work partially by stimulating expression of inducible nitric oxide (NO) synthase (iNOS). Because NO and peroxynitrite inhibit myocardial O2 consumption (MVO2), we examined whether this mechanism contributes to reduced cardiac work. In control isolated working rat hearts, cardiac work was stable for 60 min, followed by a decline from 60 to 120 min, without change in MVO2. Cardiac efficiency (work/MVO2) was therefore reduced from 60 to 120 min. Cytomix shortened the onset (within 20-40 min) and enhanced the depression in cardiac work and efficiency and inhibited MVO2 after 80 min. Mercaptoethylguanidine (MEG), an iNOS inhibitor and peroxynitrite scavenger, or the glucocorticoid dexamethasone (Dex) abolished the effects of Cytomix. iNOS expression was increased 10-fold by Cytomix and abolished by Dex but not MEG. That cytokine-induced depression in cardiac work precedes the reduction in MVO2 suggests, at least in the early response, that NO and/or peroxynitrite may not impair heart function by inhibiting mitochondrial respiration but reduce the heart's ability to utilize ATP for contractile work.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9724308     DOI: 10.1152/ajpheart.1998.275.3.H1016

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  17 in total

1.  Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra.

Authors:  Pedro J Ruiz; Eliezer Masliah; Taylor A Doherty; Ai Quach; Gary S Firestein
Journal:  Ann Rheum Dis       Date:  2006-12-19       Impact factor: 19.103

2.  Targeted gene silencing of tumor necrosis factor attenuates the negative inotropic effects of lipopolysaccharide in isolated contracting cardiac myocytes.

Authors:  R S Ramabadran; Amanda Chancey; Jesus G Vallejo; Philip M Barger; Natarajan Sivasubramanian; Douglas L Mann
Journal:  Tex Heart Inst J       Date:  2008

Review 3.  Pathophysiological roles of peroxynitrite in circulatory shock.

Authors:  Csaba Szabó; Katalin Módis
Journal:  Shock       Date:  2010-09       Impact factor: 3.454

Review 4.  The role of nitric oxide in the failing heart.

Authors:  W J Paulus
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

Review 5.  Beneficial effects of nitric oxide on cardiac diastolic function: 'the flip side of the coin'.

Authors:  W J Paulus
Journal:  Heart Fail Rev       Date:  2000-12       Impact factor: 4.214

Review 6.  Proinflammatory cytokines in heart failure: double-edged swords.

Authors:  Mona Hedayat; Mohammad Jafar Mahmoudi; Noel R Rose; Nima Rezaei
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

Review 7.  Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

Authors:  Nicola J Curtin; Csaba Szabo
Journal:  Mol Aspects Med       Date:  2013-01-29

8.  The role of nitric oxide in endotoxin-induced cardiodepression.

Authors:  Alla G Portnychenko; Olga Yu Harmatina; Anatolij V Kotsuruba; Oleksij O Moybenko
Journal:  Exp Clin Cardiol       Date:  2005

9.  Negative inotropic effects of high-mobility group box 1 protein in isolated contracting cardiac myocytes.

Authors:  Huei-Ping Tzeng; Jinping Fan; Jesus G Vallejo; Jian Wen Dong; Xiongwen Chen; Steven R Houser; Douglas L Mann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-01-25       Impact factor: 4.733

Review 10.  Tumor Necrosis Factor-α in Heart Failure: an Updated Review.

Authors:  Sarah M Schumacher; Sathyamangla V Naga Prasad
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.